As of 4:00pm ET
| +0.06 / +2.14%|
The 1 analysts offering 12-month price forecasts for Orexigen Therapeutics Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +74.22% increase from the last price of 2.87.
The current consensus among 4 polled investment analysts is to Hold stock in Orexigen Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.